Thus, confirming KellyCis83 cell line is both phenotypically and genomically distinct from the parental Kelly cell line, while maintaining MYCN amplification, a hallmark of high-risk NB, and ensuring its relevance as a model for aggressive disease. This evidence concerns the gene MYCN and neuroblastoma.